Óskar Ö Hálfdánarson (Óskar Hálfdánarson)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Prostate Cancer

Radical Prostatectomy

Intellectual Disability

Benign Prostatic Hyperplasia

Top Venues

Basic & clinical pharmacology & toxicology

Therapeutic advances in gastroenterology

Evidence-based mental health

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Óskar Ö Hálfdánarson, Jacqueline M Cohen, Øystein Karlstad, Carolyn E Cesta, Marte Helene Bjørk, Siri Eldevik Håberg, Kristjana Einarsdóttir, Kari Furu, Gissler Mika, Vidar Hjellvik, Helle Kieler, Maarit K Leinonen, Mette Nørgaard, Buket Öztürk Essen, Sinna Pilgaard Ulrichsen, Johan Reutfors, Helga Zoega
Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evidence-based mental health (2021)
Óskar Ö Hálfdánarson, Anton Pottegård, Sigrún H Lund, Margret H Ogmundsdottir, Helga M Ogmundsdottir, Helga Zoega
Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer. Basic & clinical pharmacology & toxicology 126 (6) (2020)
Óskar Ö Hálfdánarson, Katja Fall, Margret H Ogmundsdottir, Sigrún H Lund, Eiríkur Steingrímsson, Helga M Ogmundsdottir, Helga Zoega
Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study. Pharmacoepidemiology and drug safety 28 (4) (2018)
Óskar Ö Hálfdánarson, Anton Pottegård, Einar S Björnsson, Sigrún H Lund, Margret H Ogmundsdottir, Eiríkur Steingrímsson, Helga M Ogmundsdottir, Helga Zoega
Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therapeutic advances in gastroenterology 11 (2018)